Financials
- Market Capitalization 642.86 M
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2744 | CRMD CorMedix Inc. - Common Stock | 8.20 USD | -0.85% | -7.97% | -4.65% | -27.43% | 643.31 M USD | ||
| 2745 | ACHV Achieve Life Sciences, Inc. - Common Shares | 6.04 USD | -4.28% | -6.79% | +7.47% | +127.07% | 620.06 M USD | ||
| 2754 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.86 USD | +0.54% | -13.08% | -4.62% | +50.00% | 641.99 M USD | ||
| 2760 | RGNX REGENXBIO Inc. - Common Stock | 12.12 USD | -1.38% | -22.41% | +71.43% | -9.75% | 626.58 M USD |
Frequently asked questions about PTC Therapeutics, Inc. - Common Stock
What is the PTC Therapeutics, Inc. - Common Stock stock price today?
The current price of PTC Therapeutics, Inc. - Common Stock (PTCT) is 77.5. Over the past 24 hours, the stock has changed by -4.02%. Follow the PTCT chart for real-time price dynamics.
What is the stock ticker of PTC Therapeutics, Inc. - Common Stock?
PTC Therapeutics, Inc. - Common Stock trades under the ticker PTCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PTC Therapeutics, Inc. - Common Stock stock going up?
PTCT has changed by -13.19% over the last week, +2.79% over the last month, and +62.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was PTC Therapeutics, Inc. - Common Stock net income for the last quarter?
PTC Therapeutics, Inc. - Common Stock reported net income of -2.81 M for the last quarter. The previous quarter showed -134.97 M, which means net income changed by +97.92%.
How many employees does PTC Therapeutics, Inc. - Common Stock have?
As of the latest available data, PTC Therapeutics, Inc. - Common Stock has 991 employees. Workforce size can provide additional context about the company's scale and operations.
What is PTC Therapeutics, Inc. - Common Stock EBITDA?
PTC Therapeutics, Inc. - Common Stock EBITDA is 58.57 M, and its EBITDA margin is 21.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PTC Therapeutics, Inc. - Common Stock stock?
You can buy PTC Therapeutics, Inc. - Common Stock (PTCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PTC Therapeutics, Inc. - Common Stock stock?
Investing in PTC Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTCT chart and related analysis on metatrader.com as part of your research.